Menu

Pharmaxis - News, Features, and Slideshows

News

  • Carr backs venture capital to tune of $80m

    The Federal Government has injected $80 million into four Australian venture capital funds, with the aim of stimulating innovation and accelerating commercialisation in early stage Australian companies.

    Written by Renai LeMay09 Nov. 10 11:11
  • Pharmaxis shares dive 30% on trial results

    Pharmaceutical company, Pharmaxis (ASX:PXS) underwhelmed the market with the results from their phase III clinical trial of cystic fibrosis treatment drug Bronchitol®.

    Written by CFO World Staff23 June 10 16:21
Computerworld
ARN
Techworld
CMO